SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : EntreMed (ENMD) -- Ignore unavailable to you. Want to Upgrade?

To: Tom Caruthers who wrote (848)5/7/1998 12:04:00 PM
From: KM  Respond to of 2135
 
Well, in KTEL, it also has to do with the tiny float. I do a lot of short term trading, but I think this one is going to be a longer term short holding. In fact, I'm trying to bang out a bunch more, but as Briefing notes, it ain't easy to get these days. I'd take it at the market.



To: Tom Caruthers who wrote (848)5/7/1998 12:05:00 PM
From: epicure  Read Replies (2) | Respond to of 2135
 
ENMD is sort of the anti- KTEL in terms of their press releases. I must say that the management has acted very ethically in trying not to mislead anyone. I will keep an eye on this stock after it comes down.



To: Tom Caruthers who wrote (848)5/7/1998 8:03:00 PM
From: Jason Ghionis  Respond to of 2135
 
As early as Monday you couldn't find stock to short. All the holders of fully paid stock had restricted their shares. Hence, if a short squeeze was to start at some point in time it should've occured at some point today. That could have accounted for the bounce from 27 to 36. At any rate, there doesn't appear to be much holding the stock in the 30s. Especially since two major firms set a target of 25 on the stock. That would be the support.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News